{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:40:02Z","timestamp":1782351602716,"version":"3.54.5"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005909","name":"UC MEXUS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005909","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.pnpbp.2021.110301","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T05:22:49Z","timestamp":1616044969000},"page":"110301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization"],"prefix":"10.1016","volume":"110","author":[{"given":"Astrid","family":"Coronado-\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Romero-Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Mac\u00edas-Triana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Tatum-Kuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Vera-Barr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Imperatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Murillo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2021.110301_bb0005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.physbeh.2016.06.013","article-title":"Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor","volume":"164","author":"Abbassian","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejim.2018.01.001","article-title":"Medical use of cannabis and cannabinoids containing products \u2013 regulations in Europe and North America","volume":"49","author":"Abuhasira","year":"2018","journal-title":"Eur. J. Int. Med."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.forsciint.2017.02.031","article-title":"The effects of synthetic cannabinoid UR-144 on the human body-a review of 39 cases","volume":"273","author":"Adamowicz","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-030-57369-0_2","article-title":"Neuromolecular mechanisms of Cannabis action","volume":"1264","author":"Adel","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110301_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122843","article-title":"WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid \u03b21-42 effects on astrocytes in primary culture","volume":"10","author":"Aguirre-Rueda","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110301_bb0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.9740\/mhc.2019.03.093","article-title":"Review of the many faces of synthetic cannabinoid toxicities","volume":"9","author":"Alipour","year":"2019","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0035","first-page":"137","article-title":"Synthetic cannabinoid induced acute respiratory depression: case series and literature review","volume":"22","author":"Alon","year":"2017","journal-title":"Respir. Med. Case Rep."},{"issue":"9","key":"10.1016\/j.pnpbp.2021.110301_bb0040","article-title":"Cannabinoid receptors and their relationship with chronic pain: a narrative review","volume":"12","author":"Anthony","year":"2020","journal-title":"Cureus."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.physbeh.2016.12.044","article-title":"Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity","volume":"171","author":"Argueta","year":"2017","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110301_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0376-8716(99)00152-0","article-title":"Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding","volume":"60","author":"Aung","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2021.110301_bb9180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/164_2018_144","article-title":"The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution","volume":"252","author":"Banister","year":"2018","journal-title":"Handb Exp Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0060","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00192-016-2984-x","article-title":"Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats","volume":"27","author":"Bakali","year":"2016","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0065","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/164_2018_144","article-title":"The chemistry and pharmacology of synthetic cannabinoid receptor agonist new psychoactive substances: evolution","volume":"252","author":"Banister","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5604\/17322693.1213898","article-title":"Metabolism of endocannabinoids","volume":"70","author":"Biernacki","year":"2016","journal-title":"Postepy Hig. Med. Dosw."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110301_bb0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","article-title":"Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function","volume":"256","author":"Bisogno","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.addbeh.2016.07.005","article-title":"A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: characteristics and treatment outcomes","volume":"63","author":"Blevins","year":"2016","journal-title":"Addict. Behav."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2018.10.006","article-title":"The neuropsychopharmacology of cannabis: a review of human imaging studies","volume":"195","author":"Bloomfield","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110301_bb0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/npp.2017.209","article-title":"Clinical and preclinical evidence for functional interactions of cannabidiol and \u03949-tetrahydrocannabinol","volume":"43","author":"Boggs","year":"2018","journal-title":"Neuropsychopharmacology."},{"issue":"11","key":"10.1016\/j.pnpbp.2021.110301_bb0100","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1007\/s00213-019-05283-3","article-title":"The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species","volume":"236","author":"Borgan","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021917","article-title":"Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity","volume":"6","author":"Brents","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110301_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153327","article-title":"Behavioral characterization of the effects of Cannabis smoke and anandamide in rats","volume":"11","author":"Bruijnzeel","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0115","article-title":"The neuropharmacology of cannabinoid receptor ligands in central signaling pathways","author":"Brunt","year":"2020","journal-title":"Eur. J. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2021.110301_bb0120","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00702-019-02018-8","article-title":"Evidence for the use of cannabinoids in Parkinson\u2019s disease","volume":"126","author":"Buhmann","year":"2019","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110301_bb0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2017.206","article-title":"CB1 receptor Signaling in the brain: extracting specificity from ubiquity","volume":"43","author":"Busquets-Garcia","year":"2018","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbr.2012.11.018","article-title":"Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test","volume":"240","author":"Cagni","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0135","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/bja\/aex267","article-title":"Activation of cannabinoid receptor 1 is involved in protection against mitochondrial dysfunction and cerebral ischaemic tolerance induced by isoflurane preconditioning","volume":"119","author":"Cai","year":"2017","journal-title":"Br. J. Anaesth."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110301_bb0140","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/jpet.118.250530","article-title":"Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats","volume":"367","author":"Carlier","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-319-20825-1_2","article-title":"Biosynthesis and fate of endocannabinoids","volume":"231","author":"Cascio","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: epidemiology, pharmacodynamics,and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0155","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamapediatrics.2016.3624","article-title":"Association of State Recreational Marijuana Laws with Adolescent Marijuana use","volume":"171","author":"Cerd\u00e1","year":"2017","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0160","doi-asserted-by":"crossref","first-page":"E112","DOI":"10.1208\/aapsj080113","article-title":"Activation of G-proteins in brain by endogenous and exogenous cannabinoids","volume":"8","author":"Childers","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2016-2675","article-title":"Health risk Behaviors with synthetic cannabinoids versus marijuana","volume":"139","author":"Clayton","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fpubh.2018.00162","article-title":"Synthetic and non-synthetic cannabinoid drugs and their adverse effects-a review from public health prospective","volume":"6","author":"Cohen","year":"2018","journal-title":"Front. Public Health"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0175","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuropharm.2017.11.020","article-title":"Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073","volume":"134","author":"Cooper","year":"2018","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.pnpbp.2021.110301_bb0180","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/15563650.2019.1647344","article-title":"Characteristics and circumstances of synthetic cannabinoid-related death","volume":"58","author":"Darke","year":"2020","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0185","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/rcm.6673","article-title":"In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200","volume":"27","author":"De Brabanter","year":"2013","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0190","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.psychres.2018.08.012","article-title":"Psychosis and synthetic cannabinoids","volume":"268","author":"Deng","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0195","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.phrs.2012.06.004","article-title":"Stimulation of accumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats","volume":"66","author":"Deshmukh","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0200","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110301_bb0205","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1089\/can.2019.0103","article-title":"Nausea-induced conditioned gaping reactions in rats produced by high-dose synthetic cannabinoid, JWH-018","volume":"5","author":"DeVuono","year":"2020","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0210","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1006\/bbrc.2001.4354","article-title":"Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)\/VR(1) vanilloid receptor \u201chybrid\u201d ligands","volume":"281","author":"Di Marzo","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0215","article-title":"Phytocannabinoids: general aspects and pharmacological potential in neurodegenerative diseases","author":"Dos Reis Franco","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-030-57369-0_3","article-title":"Neuropharmacological effects of the main phytocannabinoids: a narrative review","volume":"1264","author":"Dos Santos","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0225","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/02791072.2016.1186305","article-title":"Synthetic cannabinoid use and descriptive norms among collegiate student-athletes","volume":"48","author":"Egan","year":"2016","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0230","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2013.12.212","article-title":"Synthetic cannabinoids: analysis and metabolites","volume":"97","author":"Elsohly","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0235","first-page":"1","article-title":"Phytochemistry of Cannabis sativa L","volume":"103","author":"Elsohly","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110301_bb0240","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.neuropharm.2012.05.013","article-title":"WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-\u03b3 pathway","volume":"63","author":"Fakhfouri","year":"2012","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0245","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fnbeh.2011.00060","article-title":"Beyond THC: the new generation of cannabinoid designer drugs","volume":"5","author":"Fattore","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0250","doi-asserted-by":"crossref","first-page":"9515","DOI":"10.3748\/wjg.v22.i43.9515","article-title":"Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK","volume":"22","author":"Feng","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0255","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/cercor\/11.8.728","article-title":"The cannabinoid receptor agonist WIN 55,212 2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study","volume":"11","author":"Ferraro","year":"2001","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0260","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/bmj.l1141","article-title":"Medicinal use of cannabis based products and cannabinoids","volume":"365","author":"Freeman","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.JAA.0000525914.28344.e2","article-title":"Synthetic cannabinoids: a review of the clinical implications of a new drug of choice","volume":"30","author":"Freund","year":"2017","journal-title":"JAAPA"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0270","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2021.110301_bb0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2007.11.053","article-title":"Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling","volume":"581","author":"Georgieva","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0280","first-page":"523","article-title":"Phytocannabinoids beyond the Cannabis plant - do they exist?","volume":"160","author":"Gertsch","year":"2010","journal-title":"Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0285","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ntt.2015.12.004","article-title":"Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice","volume":"58","author":"Gilbert","year":"2016","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0290","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2018.07.036","article-title":"Monoacylglycerol lipase (MAGL) as a promising therapeutic target","volume":"157","author":"Gil-Ord\u00f3\u00f1ez","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0295","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuroscience.2014.05.007","article-title":"Peripheral and intra-dorsolateral striatum injections of the cannabinoid receptor agonist WIN 55,212-2 impair consolidation of stimulus-response memory","volume":"274","author":"Goodman","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0300","article-title":"A pilot study into the effects of the CB1 cannabinoid receptor agonist WIN55,212-2 or the antagonist\/inverse agonist AM251 on sleep in rats","volume":"178469","author":"Goonawardena","year":"2011","journal-title":"Sleep Dis."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0305","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/FBP.0000000000000108","article-title":"Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459","volume":"26","author":"Goonawardena","year":"2015","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0310","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10517-016-3536-6","article-title":"CB-receptor agonist HU-210 mimics the postconditioning phenomenon of isolated heart","volume":"162","author":"Gorbunov","year":"2016","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0315","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/can.2017.0015","article-title":"N-Arachidonoyl dopamine: a novel endocannabinoid and Endovanilloid with widespread physiological and pharmacological activities","volume":"2","author":"Grabiec","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0320","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/FBP.0000000000000222","article-title":"Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling","volume":"27","author":"Gueye","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0325","first-page":"711","article-title":"Cannabinoid system of the lateral septum in the modulation of anxiety-like behaviors in rats","volume":"16","author":"Hajizadeh-Moghaddam","year":"2013","journal-title":"Arch. Iran Med."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0330","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1213\/ANE.0000000000000921","article-title":"Neuropeptide VF enhances cannabinoid agonist WIN55,212-2-induced antinociception in mice","volume":"121","author":"Han","year":"2015","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0335","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pbb.2015.02.007","article-title":"Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats","volume":"131","author":"Hasanein","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110301_bb0340","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/15563650.2017.1393082","article-title":"Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA","volume":"56","author":"Hermanns-Clausen","year":"2018","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0345","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/ajad.12622","article-title":"Nabilone pharmacotherapy for cannabis dependence: a randomized, controlled pilot study","volume":"26","author":"Hill","year":"2017","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0350","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-3565(24)38289-8","article-title":"Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)","volume":"289","author":"Hillard","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0355","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1111\/bph.13106","article-title":"Endocannabinoids modulate human blood-brain barrier permeability in vitro","volume":"172","author":"Hind","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0360","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S2215-0366(20)30074-2","article-title":"Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis","volume":"4","author":"Hindley","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0365","series-title":"Nabilone for the Treatment of Nausea and Vomiting or Anorexia: A Review of Clinical Effectiveness and Guidelines [Internet]","author":"Ho","year":"2019"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0370","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","article-title":"CB1 and CB2 receptor pharmacology","volume":"80","author":"Howlett","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0375","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-20825-1_3","article-title":"Distribution of the endocannabinoid system in the central nervous system","volume":"231","author":"Hu","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0380","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2174\/0929867054020864","article-title":"Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and Indenes","volume":"2","author":"Huffman","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0385","first-page":"44","article-title":"The consequences of chronic cannabis smoking in vulnerable adolescents","volume":"24","author":"Iede","year":"2017","journal-title":"Paediatr. Respir. Rev."},{"issue":"7","key":"10.1016\/j.pnpbp.2021.110301_bb0390","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00213-019-05222-2","article-title":"Effects of the synthetic cannabinoid 5F-AMB on anxiety and recognition memory in mice","volume":"236","author":"Ito","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0395","first-page":"394","article-title":"The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats","volume":"19","author":"Jahanabadi","year":"2016","journal-title":"Iran J. Basic Med. Sci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0400","series-title":"Monitoring the Future National Survey Results on Drug Use: 1975\u20132014: Overview, Key Findings on Adolescent Drug Use","author":"Johnston","year":"2015"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0405","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2131\/jts.42.335","article-title":"Pyrolysis of UR-144, a synthetic cannabinoid, augments an affinity to human CB1 receptor and cannabimimetic effects in mice","volume":"42","author":"Kaizaki-Mitsumoto","year":"2017","journal-title":"J. Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110301_bb0410","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/jpet.115.228189","article-title":"Comparisons of \u03949-tetrahydrocannabinol and anandamide on a battery of cognition-related behavior in nonhuman primates","volume":"357","author":"Kangas","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0415","doi-asserted-by":"crossref","first-page":"29817","DOI":"10.1074\/jbc.M109.050187","article-title":"Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands","volume":"284","author":"Kapur","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110301_bb0420","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/15563650.2018.1485927","article-title":"Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015)","volume":"57","author":"Kasper","year":"2019","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0425","first-page":"65","article-title":"Endocannabinoid receptors: CNS localization of the CB\u2081 cannabinoid receptor","volume":"1","author":"Katona","year":"2009","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0430","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fncel.2016.00294","article-title":"Cannabinoid receptors in the central nervous system: their signaling and roles in disease","volume":"10","author":"Kendall","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0435","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnmol.2020.00125","article-title":"Cannabinoids, endocannabinoids and sleep","volume":"13","author":"Kesner","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0440","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.drugalcdep.2016.07.018","article-title":"Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011\u20132015","volume":"166","author":"Keyes","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0445","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbr.2015.02.025","article-title":"Cannabinoids & Stress: impact of HU-210 on behavioral tests of anxiety in acutely stressed mice","volume":"284","author":"Kinden","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0450","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/cpt.115","article-title":"Medicinal chemistry of cannabinoids","volume":"97","author":"Kiran-Vemuri","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0455","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.26142","article-title":"The therapeutic potential of cannabinoids for movement disorders","volume":"30","author":"Kluger","year":"2015","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110301_bb0460","doi-asserted-by":"crossref","first-page":"413","DOI":"10.31887\/DCNS.2007.9.4\/nkogan","article-title":"Cannabinoids in health and disease","volume":"9","author":"Kogan","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2021.110301_bb0465","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8516","article-title":"Critical illness secondary to synthetic cannabinoid ingestion","volume":"3","author":"Kourouni","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110301_bb0470","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0022-3565(25)10152-3","article-title":"Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids","volume":"264","author":"Kuster","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110301_bb9179","doi-asserted-by":"crossref","first-page":"309","DOI":"10.31887\/DCNS.2017.19.3\/glafaye","article-title":"Cannabis, cannabinoids, and health","volume":"19","author":"Lafaye","year":"2017","journal-title":"Dialogues Clin Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105302","article-title":"Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities","volume":"163","author":"Lal","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0490","series-title":"2020. Drug Enforcement Administration Drug Scheduling. In: StatPearls [Internet]","author":"Lopez","year":"2020"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0495","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur. J. Int. Med."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172911","article-title":"Exposure to the cannabinoid agonist WIN 55, 212-2 in adolescent rats causes sleep alterations that persist until adulthood","volume":"874","author":"Mac\u00edas-Triana","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0505","series-title":"Cannabimimetic Indole Derivatives","author":"Makriyannis","year":"2007"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0510","first-page":"1","article-title":"Synthetic cannabinoid induced ocular self-injury","author":"Malik","year":"2020","journal-title":"Orbit."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0515","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/mp.2009.62","article-title":"Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain","volume":"14","author":"Marchalant","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0520","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2174\/1871527316666170413101839","article-title":"Synthetic cannabinoids: psychopharmacology, clinical aspects, psychotic onset","volume":"16","author":"Martinotti","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"Pt A","key":"10.1016\/j.pnpbp.2021.110301_bb0525","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuropharm.2017.10.041","article-title":"Finding order in chemical chaos - continuing characterization of synthetic cannabinoid receptor agonists","volume":"135","author":"Marusich","year":"2018","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110301_bb0530","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/jbcpp-2015-0091","article-title":"Cannabis - the Israeli perspective","volume":"27","author":"Mechoulam","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0535","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/BF01959156","article-title":"Enantiomeric cannabinoids: stereospecificity of psychotropic activity","volume":"44","author":"Mechoulam","year":"1988","journal-title":"Experientia"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0540","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0550","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/npp.2017.143","article-title":"The role of the endocannabinoid system and genetic variation in adolescent brain development","volume":"43","author":"Meyer","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2017-0982","article-title":"Prevalence and attitudes regarding marijuana use among adolescents over the past decade","volume":"140","author":"Miech","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0560","doi-asserted-by":"crossref","first-page":"110163","DOI":"10.1016\/j.pnpbp.2020.110163","article-title":"CB1 allosteric modulators and their therapeutic potential in CNS disorders","volume":"106","author":"Mielnik","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0565","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MAJ.0000000000000466","article-title":"Synthetic cannabinoids","volume":"350","author":"Mills","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0570","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-030-57369-0_4","article-title":"Emerging roles of cannabinoids and synthetic cannabinoids in clinical experimental models","volume":"1264","author":"Morales","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7","key":"10.1016\/j.pnpbp.2021.110301_bb0575","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/13543776.2016.1193157","article-title":"Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update","volume":"26","author":"Morales","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0580","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/pcan.2016.19","article-title":"The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells","volume":"19","author":"Morell","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0585","first-page":"6341","article-title":"The synthetic cannabinoid WIN 55,212-2 elicits death in human cancer cell lines","volume":"37","author":"M\u00fcller","year":"2017","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110301_bb0590","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/bph.12411","article-title":"Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS","volume":"171","author":"Murataeva","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0595","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuroscience.2016.10.011","article-title":"Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis","volume":"339","author":"Murillo-Rodr\u00edguez","year":"2016","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110301_bb0600","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2174\/1871527316666170223161908","article-title":"The endocannabinoid system modulating levels of consciousness, emotions and likely dream contents","volume":"16","author":"Murillo-Rodriguez","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0605","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/bph.14147","article-title":"Single and combined effects of plant-derived (THC, CBD) and synthetic (WIN-55,212) cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice","volume":"176","author":"Myers","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0610","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fnins.2016.00422","article-title":"Vascular dysfunction in a transgenic model of Alzheimer\u2019s disease: effects of CB1R and CB2R cannabinoid agonists","volume":"10","author":"Navarro-Dorado","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0615","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajp.2017.11.002","article-title":"Synthetic marijuana is no more marijuana","volume":"43","author":"Nayak","year":"2019","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0620","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3892\/ol.2015.3525","article-title":"Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2","volume":"10","author":"Niu","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0625","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1134\/S0006297917110141","article-title":"Neuroprotective properties of endocannabinoids N-Arachidonoyl dopamine and N-Docosahexaenoyl dopamine examined in neuronal precursors derived from human pluripotent stem cells","volume":"82","author":"Novosadova","year":"2017","journal-title":"Biochemistry (Mosc)"},{"issue":"9","key":"10.1016\/j.pnpbp.2021.110301_bb0630","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/medicina55090525","article-title":"Use of medicinal Cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): a systematic review","volume":"55","author":"Orsolini","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0635","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2016.09.010","article-title":"Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells","volume":"165","author":"Ortega","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2017-1330","article-title":"Synthetic cannabinoid use among high school seniors","volume":"140","author":"Palamar","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109865","article-title":"Biased agonism at the cannabinoid receptors \u2013 Evidence from synthetic cannabinoid receptor agonists","volume":"78","author":"Patel","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0650","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/1556-4029.13704","article-title":"Teens and spice: a review of adolescent fatalities associated with synthetic cannabinoid use","volume":"63","author":"Paul","year":"2018","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088672","article-title":"Endocannabinoid modulation of cortical up-states and NREM sleep","volume":"9","author":"Pava","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2017.11.005","article-title":"Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain","volume":"129","author":"Perdikaris","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-20825-1_1","article-title":"Endocannabinoids and their pharmacological actions","volume":"231","author":"Pertwee","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0670","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX, cannabinoid receptors and their ligands: beyond CB\u2081 and CB\u2082","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172949","article-title":"Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: implications for toxicity","volume":"195","author":"Pinson","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110301_bb0680","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/15563650.2019.1661425","article-title":"Synthetic cannabinoid receptor agonists: classification and nomenclature","volume":"58","author":"Potts","year":"2020","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0685","series-title":"Prescription of Controlled Substances: Benefits and Risks. In: StatPearls [Internet]","author":"Preuss","year":"2020"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0690","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.apha.2017.03.005","article-title":"Functional selectivity at cannabinoid receptors","volume":"80","author":"Priestley","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0695","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.taap.2013.03.012","article-title":"Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors","volume":"269","author":"Rajasekaran","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110301_bb0700","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12888-020-02813-8","article-title":"Effects of \u22069-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies","volume":"20","author":"Raymundi","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0705","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/00952990.2016.1164711","article-title":"Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana","volume":"43","author":"Richter","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0710","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/jnc.12636","article-title":"Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex","volume":"129","author":"Saez","year":"2014","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.pnpbp.2021.110301_bb0715","article-title":"Synthetic cannabinoids and its association with persistent negative symptoms of schizophrenia","volume":"12","author":"Satodiya","year":"2020","journal-title":"Cureus."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0720","article-title":"Use of Cannabis and cannabinoids in patients with Cancer","author":"Sawtelle","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0725","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1111\/bph.13892","article-title":"Cannabinoid CB1\/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia","volume":"174","author":"Scherma","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0730","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s11481-012-9351-6","article-title":"The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55","volume":"7","author":"Sharir","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173059","article-title":"Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids","volume":"199","author":"Sholler","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110301_bb0740","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020778","article-title":"Cannabis sativa L. as a natural drug meeting the criteria of a multitarget approach to treatment","volume":"22","author":"Stasi\u0142owicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.pnpbp.2021.110301_bb0745","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3390\/ijms21082778","article-title":"A guide to targeting the endocannabinoid system in drug design","volume":"21","author":"Stasiulewicz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0750","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00210-017-1417-9","article-title":"Cannabinoid receptor agonist WIN55, 212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-\u03baB pathways, Naunyn Schmiedebergs","volume":"390","author":"Su","year":"2017","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0760","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/7854_2016_60","article-title":"Pharmacological and toxicological effects of synthetic cannabinoids and their metabolites","volume":"32","author":"Tai","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","article-title":"A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment","volume":"54","author":"Tait","year":"2016","journal-title":"Clin. Toxicol."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110301_bb0770","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/medicina56010024","article-title":"Challenges and opportunities in preclinical research of synthetic cannabinoids for pain therapy","volume":"56","author":"Tamba","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0775","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1016\/S0968-0896(03)00413-9","article-title":"Synthesis and structure-activity relationships of a series of pyrrole cannabinoid receptor agonists","volume":"11","author":"Tarzia","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0780","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bph.14066","article-title":"Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study","volume":"175","author":"Theunissen","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110301_bb0785","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3565(24)37365-3","article-title":"Comparative receptor binding analyses of cannabinoid agonists and antagonists","volume":"285","author":"Thomas","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0790","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2018.04.054","article-title":"Enhanced endocannabinoid tone as a potential target of pharmacotherapy","volume":"204","author":"Toczek","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0795","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpba.2017.12.016","article-title":"Excretion of metabolites of the synthetic cannabinoid JWH-018 in urine after controlled inhalation","volume":"150","author":"Toennes","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0800","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/08897077.2016.1219438","article-title":"Acute effects of synthetic cannabinoids: update 2015","volume":"38","author":"Tournebize","year":"2017","journal-title":"Subst. Abus."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110301_bb0805","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/phar.1709","article-title":"Nabilone for the management of pain","volume":"36","author":"Tsang","year":"2016","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0810","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41232-018-0086-5","article-title":"Endocannabinoids and related N-acylethanolamines: biological activities and metabolism","volume":"38","author":"Tsuboi","year":"2018","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0815","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fphar.2016.00317","article-title":"Impact of Cannabis, cannabinoids, and endocannabinoids in the lungs","volume":"7","author":"Turcotte","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0820","series-title":"Marijuana Toxicity. 2020 Jul 19. In: StatPearls [Internet]","author":"Turner","year":"2020"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0825","series-title":"Analysis of Drug Markets: Opiates, Cocaine, Cannabis, Synthetic Drugs","article-title":"World drug report 2018","author":"United Nations Office on Drugs and Crime","year":"2018"},{"key":"10.1016\/j.pnpbp.2021.110301_bb0830","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s12640-017-9839-1","article-title":"Cannabinoid receptor type 1 agonist ACEA protects neurons from death and attenuates endoplasmic reticulum stress-related apoptotic pathway signaling","volume":"33","author":"Vrechi","year":"2018","journal-title":"Neurotox. Res."},{"issue":"7","key":"10.1016\/j.pnpbp.2021.110301_bb0835","article-title":"Cannabinoids for fibromyalgia","volume":"7","author":"Walitt","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0840","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(02)02331-2","article-title":"Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity","volume":"452","author":"Wallace","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.pnpbp.2021.110301_bb0845","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.3390\/ijms21176115","article-title":"Molecular pharmacology of synthetic cannabinoids: delineating CB1 receptor-mediated cell Signaling","volume":"21","author":"Walsh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.pnpbp.2021.110301_bb0850","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.3390\/ijms21176115","article-title":"Molecular pharmacology of synthetic cannabinoids: delineating CB1 receptor-mediated cell Signaling","volume":"21","author":"Walsh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0855","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1037\/1064-1297.12.3.173","article-title":"A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats","volume":"12","author":"Wiley","year":"2004","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0860","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.11.035","article-title":"Comparison of the discriminative stimulus and response rate effects of \u03949-tetrahydrocannabinol and synthetic cannabinoids in female and male rats","volume":"172","author":"Wiley","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0865","first-page":"4707","article-title":"The use of styrene maleic acid Nanomicelles encapsulating the synthetic cannabinoid Analog WIN55,212-2 for the treatment of Cancer","volume":"35","author":"Xian","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0870","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.3892\/mmr.2015.4477","article-title":"Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells","volume":"12","author":"Xu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0885","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/cbf.3194","article-title":"Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2","volume":"34","author":"Zhang","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.pnpbp.2021.110301_bb0890","first-page":"5664","article-title":"Elevation of arachidonoylethanolamide levels by activation of the endocannabinoid system protects against colitis and ameliorates remote organ lesions in mice","volume":"14","author":"Zhao","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110301_bb0895","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621000609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621000609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:56:37Z","timestamp":1759521397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584621000609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":173,"alternative-id":["S0278584621000609"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110301","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110301"}}